Veracyte Announces Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- European stocks rise as markets stabilise, dollar set for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Veracyte (VCYT) Halted on LUDP
November 7, 2017 9:31 AM ESTVeracyte (NASDAQ: VCYT) Halted on LUDP
... MoreVeracyte, Inc (VCYT) PT Lowered to $9 at Leerink Partners
November 7, 2017 8:10 AM ESTLeerink Partners lowered its price target on Veracyte, Inc (NASDAQ: VCYT) to $9.00 (from $12.00) while maintaining an Outperform rating following lower than expected Q3 revenue and guidance.
Analyst Puneet Souda is keeping the Outperform rating on the view that the company offers differentiated negative... More
Veracyte (VCYT) Tops Q3 EPS by 2c
November 6, 2017 4:19 PM ESTVeracyte (NASDAQ: VCYT) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $17.5 million versus the consensus estimate of $19.55 million.
We delivered a solid performance this quarter in which we grew our genomic test... More



